The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
Trump adds seven countries to full travel ban list
Indian parliament votes to allow private firms in nuclear power sector
Doctors in England start five-day walkout during flu surge
Israeli settler kills 16-year-old Palestinian in West Bank, mayor says
Paris' Louvre reopens partially but staff vote to extend strike
